+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID07573735

Observational Study of Cell-free DNA and Skin Immune Response in Adults with Atopic Dermatitis

Led by Zhongda Hospital · Updated on 2026-06-11

80

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Atopic dermatitis AD, also known as eczema, is a chronic skin condition marked by intense itching and skin barrier damage caused by an overactive immune system. Researchers are investigating the role of circulating cell-free DNA cfDNA as a potential trigger in this disease. This study aims to compare cfDNA levels in blood between people with AD and healthy volunteers, and to explore how skin immune cells respond to this DNA by activating the STING pathway. Participants include individuals diagnosed with AD and healthy volunteers. Researchers will collect blood samples and, for some AD patients, small skin biopsies to analyze cfDNA levels and immune cell activity. The study will measure the density of skin macrophages expressing STING protein and assess disease severity using skin scoring methods such as SCORAD and EASI. During the study, participants will undergo dermatological evaluations and provide samples for laboratory analysis. Researchers will use these data to explore connections between cfDNA levels, skin immune responses, and AD severity. The study helps to understand disease mechanisms that may improve future monitoring and treatment approaches. Participation lasts according to study schedules until primary outcome data collection is complete.

CONDITIONS

Brief Title

Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here